Search

Author/Creator Tobin, Joshua

1. Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials. (31st December 2022)

Authors:
Tobin, Joshua; Ford, Janet H.; Tockhorn-Heidenreich, Antje; Nichols, Russell M.; Ye, Wenyu; Bhandari, Rohit; Mi, Xiaojuan; Sharma, Karan; Lipton, Richard B.
Journal:
Journal of medical economics
Issue:
Volume 25:Number 1(2022)
Page Start:
630
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma. (24th July 2019)

Authors:
Keane, Colm; Tobin, Joshua; Gunawardana, Jay; Francis, Santiyagu; Gifford, Grace; Gabrielli, Sara; Gill, Anthony; Stevenson, William; Talaulikar, Dipti; Gould, Clare; Jain, Sanjiv; Birch, Simone; Hertzberg, Mark; Gandhi, Maher K.
Journal:
European journal of haematology
Issue:
Volume 103:Number 3(2019)
Page Start:
200
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗